Related Experiment Video
Updated: Jul 18, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
Newer agents for the management of overactive bladder
Benjamin J Epstein1, John G Gums, Emerson Molina
1University of Florida, Gainesville, Florida, USA. epstein@cop.ufl.edu
Newer overactive bladder medications like trospium, solifenacin, and darifenacin offer improved tolerability over older anticholinergics. While generally as effective, individual patient factors guide optimal selection for managing urinary incontinence.
Area of Science:
- Pharmacology
- Urology
Background:
- Older anticholinergics (tolterodine, oxybutynin) for overactive bladder (OAB) cause side effects due to non-selective muscarinic receptor activity.
- Newer agents (trospium, solifenacin, darifenacin) approved in 2004 offer potential for improved tolerability and bladder selectivity.
Purpose of the Study:
- To review the efficacy and tolerability of newer OAB medications compared to older agents.
- To highlight pharmacokinetic differences for personalized treatment selection.
Main Methods:
- Review of clinical trials comparing newer OAB agents (trospium, solifenacin, darifenacin) with placebo and older agents (oxybutynin, tolterodine).
- Analysis of studies assessing effects on incontinence episodes, voiding frequency, urgency, and quality of life.
Main Results:
- Newer agents effectively reduce incontinence, voiding frequency, and urgency, improving quality of life compared to placebo.
- Head-to-head trials suggest newer agents are better tolerated than immediate-release older drugs, with similar effectiveness.
- Solifenacin showed a trend towards greater efficacy than extended-release tolterodine in one study, with comparable tolerability.
Conclusions:
- Newer OAB medications demonstrate comparable efficacy to older agents, with potentially improved tolerability.
- Pharmacokinetic profiles and individual patient factors are crucial for selecting the most appropriate OAB treatment.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Urinary Tract Infection IV: Nursing Management
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Urinary Tract Calculi V: Nursing Management